Literature DB >> 23401860

Monoubiquitination of filamin B regulates vascular endothelial growth factor-mediated trafficking of histone deacetylase 7.

Yu-Ting Su1, Chengzhuo Gao, Yu Liu, Shuang Guo, Anthony Wang, Benlian Wang, Hediye Erdjument-Bromage, Masaru Miyagi, Paul Tempst, Hung-Ying Kao.   

Abstract

Nucleocytoplasmic shuttling of class IIa of histone deacetylases (HDACs) is a key mechanism that controls cell fate and animal development. We have identified the filamin B (FLNB) as a novel HDAC7-interacting protein that is required for temporal and spatial regulation of vascular endothelial growth factor (VEGF)-mediated HDAC7 cytoplasmic sequestration. This interaction occurs in the cytoplasm and requires monoubiquitination of an evolutionarily conserved lysine 1147 (K1147) in the immunoglobulin (Ig)-like repeat 10 (R10) of FLNB and the nuclear localization sequence of HDAC7. Inhibition of protein kinase C (PKC) blocks VEGF-induced ubiquitination of FLNB and its interaction with HDAC7. Small interfering RNA (siRNA) knockdown of FLNB or ubiquitin (Ub) in human primary endothelial cells blocks VEGF-mediated cytoplasmic accumulation of HDAC7, reduces VEGF-induced expression of the HDAC7 target genes Mmp-10 and Nur77, and inhibits VEGF-induced vascular permeability. Using dominant negative mutants and rescue experiments, we demonstrate the functional significance of FLNB K1147 to interfere with the ability of phorbol myristate acetate (PMA) to promote FLNB-mediated cytoplasmic accumulation of HDAC7. Taken together, our data show that VEGF and PKC promote degradation-independent protein ubiquitination of FLNB to control intracellular trafficking of HDAC7.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23401860      PMCID: PMC3624255          DOI: 10.1128/MCB.01146-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.

Authors:  U Dressel; P J Bailey; S C Wang; M Downes; R M Evans; G E Muscat
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

2.  Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.

Authors:  H Y Kao; M Downes; P Ordentlich; R M Evans
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

Review 3.  Regulatory signal transduction pathways for class IIa histone deacetylases.

Authors:  Maribel Parra; Eric Verdin
Journal:  Curr Opin Pharmacol       Date:  2010-05-04       Impact factor: 5.547

4.  Rapid elimination of the histone variant MacroH2A from somatic cell heterochromatin after nuclear transfer.

Authors:  Ching-Chien Chang; Shaorong Gao; Li-Ying Sung; Gareth N Corry; Yinghong Ma; Zsolt Peter Nagy; X Cindy Tian; Theodore P Rasmussen
Journal:  Cell Reprogram       Date:  2010-02       Impact factor: 1.987

5.  Histone deacetylase 7 (HDAC7) regulates myocyte migration and differentiation.

Authors:  Chengzhuo Gao; Yu Liu; Minh Lam; Hung-Ying Kao
Journal:  Biochim Biophys Acta       Date:  2010-07-16

6.  Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions.

Authors:  C J Loy; K S Sim; E L Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

7.  VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin.

Authors:  Julie Gavard; J Silvio Gutkind
Journal:  Nat Cell Biol       Date:  2006-10-22       Impact factor: 28.824

Review 8.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

9.  Upregulated histone deacetylase 1 expression in pancreatic ductal adenocarcinoma and specific siRNA inhibits the growth of cancer cells.

Authors:  Dao-Jian Gao; Min Xu; Yu-Qi Zhang; Yi-Qi Du; Jun Gao; Yan-Fang Gong; Xiao-Hua Man; Hong-Yu Wu; Jing Jin; Guo-Ming Xu; Zhao-Shen Li
Journal:  Pancreas       Date:  2010-10       Impact factor: 3.327

10.  VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis.

Authors:  Chang Hoon Ha; Bong Sook Jhun; Hung-Ying Kao; Zheng-Gen Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

View more
  14 in total

Review 1.  The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.

Authors:  Lisa Dwane; William M Gallagher; Tríona Ní Chonghaile; Darran P O'Connor
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

2.  Novel Targeting of Transcription and Metabolism in Glioblastoma.

Authors:  Yu-Ting Su; Robert Chen; Herui Wang; Hua Song; Qi Zhang; Li-Yuan Chen; Hallie Lappin; Gabriel Vasconcelos; Adrian Lita; Dragan Maric; Aiguo Li; Orieta Celiku; Wei Zhang; Kristan Meetze; Thomas Estok; Mioara Larion; Mones Abu-Asab; Zhengping Zhuang; Chunzhang Yang; Mark R Gilbert; Jing Wu
Journal:  Clin Cancer Res       Date:  2017-12-18       Impact factor: 12.531

3.  PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression.

Authors:  Teresa Gagliano; Kalpit Shah; Sofia Gargani; Liyan Lao; Mansour Alsaleem; Jianing Chen; Vasileios Ntafis; Penghan Huang; Angeliki Ditsiou; Viviana Vella; Kritika Yadav; Kamila Bienkowska; Giulia Bresciani; Kai Kang; Leping Li; Philip Carter; Graeme Benstead-Hume; Timothy O'Hanlon; Michael Dean; Frances Mg Pearl; Soo-Chin Lee; Emad A Rakha; Andrew R Green; Dimitris L Kontoyiannis; Erwei Song; Justin Stebbing; Georgios Giamas
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

4.  RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma.

Authors:  Bin Lv; Yida Pan; Daisen Hou; Ping Chen; Jun Zhang; Yiwei Chu; Mingqi Li; Yan Zeng; Dongqin Yang; Jie Liu
Journal:  Oncogene       Date:  2022-03-02       Impact factor: 9.867

5.  β-Transducin repeat-containing protein 1 (β-TrCP1)-mediated silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) protein degradation promotes tumor necrosis factor α (TNFα)-induced inflammatory gene expression.

Authors:  Kuo-Sheng Hsu; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

6.  MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment.

Authors:  Yu-Ting Su; Madison Butler; Meili Zhang; Wei Zhang; Hua Song; Lee Hwang; Andy D Tran; Ryan E Bash; Allison N Schorzman; Ying Pang; Guangyang Yu; William C Zamboni; Xiaodong Wang; Stephen V Frye; Christopher Ryan Miller; Dragan Maric; Masaki Terabe; Mark R Gilbert; Henry Shelton Earp Iii; Jing Wu
Journal:  Neurooncol Adv       Date:  2020-06-03

Review 7.  Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies.

Authors:  Maria Vähätupa; Tero A H Järvinen; Hannele Uusitalo-Järvinen
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

Review 8.  Post-translational regulation of ubiquitin signaling.

Authors:  Lei Song; Zhao-Qing Luo
Journal:  J Cell Biol       Date:  2019-04-18       Impact factor: 10.539

9.  Control of antioxidative response by the tumor suppressor protein PML through regulating Nrf2 activity.

Authors:  Shuang Guo; Xiwen Cheng; Jun-Hee Lim; Yu Liu; Hung-Ying Kao
Journal:  Mol Biol Cell       Date:  2014-06-18       Impact factor: 4.138

Review 10.  DUBs Activating the Hedgehog Signaling Pathway: A Promising Therapeutic Target in Cancer.

Authors:  Francesca Bufalieri; Ludovica Lospinoso Severini; Miriam Caimano; Paola Infante; Lucia Di Marcotullio
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.